These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25639838)

  • 21. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of differences in dose and frequency of teriparatide on bone structure in Proximal Femur. - Analysis by DXA-based 3D-modeling (3D-SHAPER Software) -TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineraL density increase and BONE structure).
    Takada J; Okimoto N; Tsukamoto M; Akatsuka T; Takebayashi T; Iba K; Ikeda S
    Arch Osteoporos; 2024 Jul; 19(1):55. PubMed ID: 38954145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential treatment of teriparatide and alendronate versus alendronate alone for elevation of bone mineral density and prevention of refracture after percutaneous vertebroplasty in osteoporosis: a prospective study.
    Yang D; Tan J; Long Y; Huang K; Han W; Wang M; Zhu S; Zeng S; Yi W
    Aging Clin Exp Res; 2023 Mar; 35(3):531-539. PubMed ID: 36708462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.
    Chevalier Y; Quek E; Borah B; Gross G; Stewart J; Lang T; Zysset P
    Bone; 2010 Jan; 46(1):41-8. PubMed ID: 19800436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis.
    Cosman F; Nieves JW; Dempster DW
    J Bone Miner Res; 2017 Feb; 32(2):198-202. PubMed ID: 27925287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
    Devogelaer JP; Adler RA; Recknor C; See K; Warner MR; Wong M; Krohn K
    J Rheumatol; 2010 Jan; 37(1):141-8. PubMed ID: 19918047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans.
    Keaveny TM; Hoffmann PF; Singh M; Palermo L; Bilezikian JP; Greenspan SL; Black DM
    J Bone Miner Res; 2008 Dec; 23(12):1974-82. PubMed ID: 18684084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy.
    Hofstetter B; Gamsjaeger S; Varga F; Dobnig H; Stepan JJ; Petto H; Pavo I; Klaushofer K; Paschalis EP
    Osteoporos Int; 2014 Dec; 25(12):2709-19. PubMed ID: 25037600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
    Huuskonen J; Arnala I; Olkkonen H; Alhava E
    Ann Chir Gynaecol; 2001; 90(2):109-14. PubMed ID: 11459259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of combination of alendronate and human parathyroid hormone(1-34) on bone strength are synergistic in the lumbar vertebra and additive in the femur of C57BL/6J mice.
    Johnston S; Andrews S; Shen V; Cosman F; Lindsay R; Dempster DW; Iida-Klein A
    Endocrinology; 2007 Sep; 148(9):4466-74. PubMed ID: 17569757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass.
    McClung MR; San Martin J; Miller PD; Civitelli R; Bandeira F; Omizo M; Donley DW; Dalsky GP; Eriksen EF
    Arch Intern Med; 2005 Aug 8-22; 165(15):1762-8. PubMed ID: 16087825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate.
    Gamsjaeger S; Buchinger B; Zoehrer R; Phipps R; Klaushofer K; Paschalis EP
    Bone; 2011 Dec; 49(6):1160-5. PubMed ID: 21893225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
    Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
    Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture.
    Hiligsmann M; Williams SA; Fitzpatrick LA; Silverman SS; Weiss R; Reginster JY
    Semin Arthritis Rheum; 2019 Oct; 49(2):184-196. PubMed ID: 30737062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: results from the EUROFORS study.
    Borggrefe J; Graeff C; Nickelsen TN; Marin F; Glüer CC
    J Bone Miner Res; 2010 Mar; 25(3):472-81. PubMed ID: 19778182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Teriparatide and Ibandronate on Cortical Bone in New Zealand White Rabbits: A HR-QCT Study.
    Iwamoto J; Seki A; Nango N
    Calcif Tissue Int; 2016 Nov; 99(5):535-542. PubMed ID: 27465620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proximal Femur Responses to Sequential Therapy With Abaloparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis by 3D Modeling of Hip Dual-Energy X-Ray Absorptiometry (DXA).
    Winzenrieth R; Kostenuik P; Boxberger J; Wang Y; Humbert L
    JBMR Plus; 2022 Apr; 6(4):e10612. PubMed ID: 35434451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparable effects of alendronate and strontium ranelate on femur in ovariectomized rats.
    Chen B; Li Y; Yang X; Xie D
    Calcif Tissue Int; 2013 Nov; 93(5):481-6. PubMed ID: 23897224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
    Deal C; Omizo M; Schwartz EN; Eriksen EF; Cantor P; Wang J; Glass EV; Myers SL; Krege JH
    J Bone Miner Res; 2005 Nov; 20(11):1905-11. PubMed ID: 16234962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial.
    Greenspan SL; Beck TJ; Resnick NM; Bhattacharya R; Parker RA
    J Bone Miner Res; 2005 Sep; 20(9):1525-32. PubMed ID: 16059624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.